These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 16034905)

  • 1. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Gordon PA; Winer JB; Hoogendijk JE; Choy EH
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003643. PubMed ID: 22895935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive agents for myasthenia gravis.
    Hart IK; Sathasivam S; Sharshar T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005224. PubMed ID: 17943844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003217. PubMed ID: 16034892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
    Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on therapy for refractory dermatomyositis and polymyositis.
    Villalba L; Adams EM
    Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K; Vincze M
    Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.